Your browser doesn't support javascript.
loading
Persistent Colonization of Ciprofloxacin-Resistant and Extended-Spectrum ß-Lactamase (ESBL)-Producing Salmonella enterica Serovar Kentucky ST198 in a Patient with Inflammatory Bowel Disease.
Jiang, Yue; Yang, Huilin; Wang, Zhen-Yu; Lin, Da-Chuan; Jiao, Xinan; Hu, Yunlong; Wang, Jing.
Affiliation
  • Jiang Y; Jiangsu Key Laboratory of Zoonosis, Yangzhou University, Yangzhou, 225009, People's Republic of China.
  • Yang H; Key Laboratory of Prevention and Control of Biological Hazard Factors (Animal Origin) for Agrifood Safety and Quality, Ministry of Agriculture of China, Yangzhou University, Yangzhou, 225009, People's Republic of China.
  • Wang ZY; Department of Clinical Laboratory, Peking University Shenzhen Hospital, Shenzhen, 518036, People's Republic of China.
  • Lin DC; Jiangsu Key Laboratory of Zoonosis, Yangzhou University, Yangzhou, 225009, People's Republic of China.
  • Jiao X; Key Laboratory of Prevention and Control of Biological Hazard Factors (Animal Origin) for Agrifood Safety and Quality, Ministry of Agriculture of China, Yangzhou University, Yangzhou, 225009, People's Republic of China.
  • Hu Y; Guangdong Key Laboratory of Regional Immunity and Diseases, Shenzhen University School of Medicine, Shenzhen University, Shenzhen, 518060, People's Republic of China.
  • Wang J; Jiangsu Key Laboratory of Zoonosis, Yangzhou University, Yangzhou, 225009, People's Republic of China.
Infect Drug Resist ; 17: 1459-1466, 2024.
Article in En | MEDLINE | ID: mdl-38628240
ABSTRACT

Objective:

Salmonella enterica serovar Kentucky ST198 has emerged as a global threat to humans. In this study, we aimed to characterize the prolonged carriage of ciprofloxacin-resistant and extended-spectrum ß-lactamase (ESBL)-producing S. Kentucky ST198 in a single patient with inflammatory bowel disease (IBD).

Methods:

Three S. Kentucky strains were collected from a single patient with IBD on 11th January, 23rd January, and 8th February, 2022, respectively. Antimicrobial susceptibility testing, whole-genome sequencing, and phylogenetic analysis with 38 previously described Chinese S. Kentucky ST198 strains from patients and food were performed.

Results:

All three S. Kentucky isolates belonged to ST198. They carried identical 16 resistance genes, such as blaCTX-M-55, tet(A), and qnrS1, and had identical mutations within gyrA (S83F and D87N) and parC (S80I). Therefore, they exhibited identical multidrug-resistant profiles, including the clinically important antibiotics cephalosporins (ceftazidime and cefepime), fluoroquinolones (ciprofloxacin and levofloxacin), and third-generation tetracycline (tigecycline). Our three S. Kentucky strains were classified into the subclade ST198.2-2, and were genetically identical (2-6 SNPs) to each other. They exhibited a close genetic similarity (15-20 SNPs) to the isolate NT-h3189 from a patient and AH19MCS1 from chicken meat in China, indicating a possible epidemiological link between these S. Kentucky ST198 isolates from the patients and chicken meat.

Conclusion:

Long-term colonization of ciprofloxacin-resistant and ESBL-producing S. Kentucky ST198 in a single patient is a matter of concern. Due to the potential transfer of S. Kentucky ST198 from food sources to humans, ongoing surveillance of this particular clone in animals, animal-derived food products, and humans should be strengthened.
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Infect Drug Resist Year: 2024 Document type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Infect Drug Resist Year: 2024 Document type: Article
...